Sa1934 Pharmacokinetics and Exposure-Response Relationships of Ustekinumab during IV Induction and SC Maintenance Treatment of Patients with Crohn's Disease with Ustekinumab: Results from the UNITI-1, UNITI-2, and IM-UNITI StudiesOmoniyi J. Adedokun, William J. Sandborn, Hugh M. Davis et al.|Gastroenterology|2016Cited by 14
832 Pharmacokinetics and Exposure-Response Relationships of Ustekinumab in Patients With Ulcerative Colitis: Results From the UNIFI Induction and Maintenance StudiesOmoniyi J. Adedokun, William J. Sandborn, Zhenhua Xu et al.|The American Journal of Gastroenterology|2019Cited by 2
Tu1749 – Pharmacokinetics and Exposure-Response Relationships of Intravenously Administered Ustekinumab During Induction Treatment in Patients with Ulcerative Colitis: Results from the Unifi Induction StudyOmoniyi J. Adedokun, William J. Sandborn, Bruce E. Sands et al.|Gastroenterology|2019Cited by 1